SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-05-000016
Filing Date
2005-05-13
Accepted
2005-05-13 14:03:07
Documents
1
Period of Report
2005-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3837
  Complete submission text file 0000882796-05-000016.txt   5838
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENAERA CORP 5110 CAMPUS DDRIVE PLYMOUTH MEETING PA 19462
Business Address C/O GENAERA CORP 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 610 941 4020
HOROVITZ ZOLA P (Reporting) CIK: 0001033507 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 05828178